The Investigational Drug MLN0264 First-in-human, First in Class ADC Targeting GCC: Phase I Dose-escalation Study and Supportive Scientific Rationale
European Journal of Cancer（2012）
关键词
investigational drug mln0264,class adc,gcc,first-in-human,dose-escalation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要